EMBARGOED FOR RELEASE UNTIL 1 PM ET, April 29, 2004

Cells from Adult Bone Marrow Can Be Converted into Brain Stem Cells Suitable for Transplantation

San Francisco -

Hope for people with Parkinson’s disease, Alzheimer’s disease, stroke and other neurodegenerative diseases may ultimately come from their own bodies. Research that will be presented at the American Academy of Neurology 56th Annual Meeting in San Francisco, Calif., April 24 – May 1, 2004, shows that cells taken from adult human bone marrow can be converted into brain stem cells that meet the criteria for transplantation into the brain. “It’s exciting to think that some day a person with Alzheimer’s disease could use their own bone marrow to create brain cells that could potentially restore their functioning and make up for cells that were lost,” said study author and neurologist Alexander Storch, MD, of the University of Ulm in Ulm, Germany. Use of the cells from adult human bone marrow, called stromal cells, eliminates the ethical and logistical issues that arise with the use of cells from fetal tissue, Storch said. And use of cells from bone marrow that would be converted and transplanted into the same person’s brain eliminates ethical issues and immune-system problems that can arise when the body rejects cells from an outside source. For the study, the researchers took the adult human bone marrow stromal cells and cultured them with growth factors. Other benefits of this process are that the cells can be converted quickly – within a few weeks – and a small amount of bone marrow can produce a large amount of converted cells, Storch said. More research is needed before the converted cells can be tested in humans. Animal studies are under way to explore the regenerative potential of the converted cells in animal models of acute and chronic neurodegenerative disorders, such as stroke and Parkinson’s disease. The researchers also need to determine the best way to administer the cells into the brain. The study was supported by the Interdisciplinary Center for Clinical Research, Ulm, the Polish-German Cooperation in Neuroscience Program, and the Landesstiftung Baden-Württemberg.

The American Academy of Neurology is the leading voice in brain health. As the world’s largest association of neurologists and neuroscience professionals with more than 44,000 members, the AAN provides access to the latest news, science and research affecting neurology for patients, caregivers, physicians and professionals alike. The AAN’s mission is to enhance member career fulfillment and promote brain health for all. A neurologist is a doctor who specializes in the diagnosis, care and treatment of brain, spinal cord and nervous system diseases such as Alzheimer's disease, stroke, concussion, epilepsy, Parkinson's disease, multiple sclerosis, headache and migraine.

Explore the latest in neurological disease and brain health, from the minds at the AAN at AAN.com or find us on Facebook, X, LinkedIn, Instagram and YouTube.

Editor's Notes: Dr. Storch will present this research during a scientific session at the 56th Annual Meeting at 2:00 p.m. PT, Friday, April 30, in Room 310 of the Moscone Convention Center. He will be available for media questions during a briefing at 10:00 a.m. PT, Thursday, April 29, in the on-site Press Interview Room, Room 214.